Skip to main content
World Journal of Otorhinolaryngology - Head and Neck Surgery logoLink to World Journal of Otorhinolaryngology - Head and Neck Surgery
. 2021 Jun 29;7(3):221–227. doi: 10.1016/j.wjorl.2021.05.002

Pediatric drug-induced sleep endoscopy: An updated review of the literature

Jill M Arganbright a,b,, Jason C Lee c, Robert A Weatherly a,b
PMCID: PMC8356111  PMID: 34430829

Abstract

The field of drug-induced sleep endoscopy (DISE) has grown considerably over the last 10∼15 years, to now include its use in pediatric patients. In this review article, we outline our approach to the use of this technology in Children with Airway Obstruction, most specifically in the management of children with airway obstruction and known or suspected adenotonsillar enlargement.

Keywords: Drug-induced sleep endoscopy, Pediatric obstructive sleep apnea, Adenotonsillectomy in children

Introduction

Obstructive sleep apnea (OSA) has a prevalence of 1%∼4% for children in the United States.1 Sequelae from pediatric OSA can include daytime somnolence, poor school performance, behavioral and neurocognitive problems, cardiovascular complications, enuresis, growth retardation,2 and an overall significantly reduced quality of life.3 Adenotonsillar hypertrophy has been widely recognized as the most significant contributor to OSA for otherwise healthy children.2 The American Academy of Pediatrics considers adenotonsillectomy (AT) to be first-line treatment for pediatric OSA.4 However, a recent meta-analysis reported residual obstructive symptoms in 33.7% of children post AT.5 For patients with persistent obstructive symptoms following AT, overnight polysomnography (PSG) is often considered the next step in evaluation. While PSG findings are helpful in determining the presence and severity of OSA, they do not identify the specific location/anatomic cause of the obstruction. Awake flexible endoscopy can be useful in assessing for certain anatomic causes of obstruction including lingual tonsil hypertrophy and adenoid re-growth; however, these awake exams have not been shown to be representative of the patient's airway while asleep. An article by Lee et al reported that awake flexible endoscopy findings did not correlate to a similar scope with the patient asleep when assessing base of tongue collapse.6 Chen et al7 demonstrated that patterns of obstruction at the level of the lateral pharyngeal wall significantly differed in awake endoscopy compared to when the patient was asleep. The evolution of induced sleep endoscopy has allowed providers to assess anatomical sites causing airway obstruction exclusively during sleep.

Sleep endoscopy was initially pioneered by Croft and Pringle in 1989 and further developed in the 1990s.8 It was named “drug-induced sleep endoscopy” (DISE) in 2005 by Kezirian and Hohenhorst.2,9 The DISE technique involves an evaluation of the upper airway using a flexible endoscope while patients are in a pharmacologically induced sleep-like state. The scope is passed through the nares to examine the nasopharynx, oropharynx, larynx, and in some cases the trachea. The procedure has been shown to be safe, with test-retest reliability and moderate-substantial inter-rater reliability.10 The goal of the DISE exam is to identify the site(s) of obstruction best to target surgically for the management of pediatric OSA. Controversy remains, however, as to how well DISE simulates physiologic sleep and, by extension, its utility in improving OSA.11 DISE has classically been used to assess patients with persistent OSA after AT. More recently, DISE is being used for certain surgically naïve patients, further expanding the indications for and utility of DISE. DISE and its impact on treatment of pediatric OSA is a very active area of ongoing research.

The goal of this review article is to summarize the current literature on pediatric DISE, specifically examining the following areas of interest: indications for DISE, anesthetic protocols, comparison of DISE to other diagnostic modalities, DISE scoring systems, the use of DISE in surgically naïve patients, and DISE-directed surgical outcomes.

Indications for DISE

As the role of DISE continues to be studied, indications for the procedure have expanded: ① persistent OSA after AT,② prior to AT for patient at high risk for persistent OSA (i.e. obesity, Down syndrome, craniofacial anomalies, neurologic impairment),③ significant symptoms of SDB or OSA with small tonsils and adenoids,④ occult or sleep-state dependent laryngomalacia,⑤ evaluation for candidacy for hypoglossal nerve stimulator procedure. The most well-studied indication for DISE is for a child with persistent OSA following AT. A 2016 systematic review revealed that at least one site of obstruction was identified in 100% of children who underwent DISE (n = 162).2,12 Wilcox et al2 in 2017 summarized studies using DISE to identify sites of obstruction in children with persistent OSA after AT; they found eight studies reporting that sites were identified in 89%∼100% of non-control patients. In 2017, Friedman et al13 surveyed pediatric otolaryngologists; they found strong agreement from responders in performing DISE for such patients with residual OSA following AT regardless of comorbidities. Additionally, a plethora of recent literature has explored the role of DISE in surgically naïve patients. Studies have shown a benefit in performing DISE prior to AT in patients who have a relatively high risk of persistent OSA following AT, including those with obesity, Down syndrome, craniofacial anomalies, and neurologic impairment.14, 15, 16 DISE in these patients can be useful in guiding management should residual disease persist following AT.16 However, opponents of this algorithm argue that airway dynamics change significantly following AT, such that the results of the pre-procedure DISE are low yield as the airway dynamics will be greatly changed following AT.13 Other situations where DISE can be helpful in surgically naïve patients include children with severe symptoms of sleep-disordered breathing (SDB) or those with OSA and small tonsils/adenoids on exam. Miller et al showed that small tonsils (1+) were not obstructive in most cases during DISE, and therefore additional sites of obstruction should be considered in lieu of proceeding with AT.17 A study by Richter et al18 highlighted the importance of identifying patients with sleep-state dependent laryngomalacia. This disease entity is difficult to identify on awake laryngoscopy alone.19 In a meta-analysis by Camacho et al,20 48/62 (77.4%) of children diagnosed with sleep-state laryngomalacia had failed prior AT. Lastly, children who are being evaluated for hypoglossal nerve stimulator (HNS) treatment currently require DISE evaluation to be completed to determine candidacy for this procedure. Caloway et al21 2019 published data from 20 patients undergoing HNS in the current ongoing pediatric clinical trial. Circumferential collapse at the level of the velopharynx was considered a criterion for exclusion from the study.

Anesthetic protocols

In an ideal setting, the anesthetic for DISE should simulate a natural sleep state while allowing for spontaneous ventilation.22 The anesthetic should not cause artificial respiratory depression, cardiovascular effects, or airway collapse beyond what is occurring in natural sleep. It should be repeatable, have a quick onset, be short in duration, and not result in excessive airway secretions.23 While no medication or combination of medications meets all these criteria precisely, there is an extensive, ongoing effort to find a protocol that most closely aligns with these ideals.

During the DISE procedure, most children require some type of inhalational anesthetic agent before intravenous (IV) line insertion. Topical anesthetic of the nasal passage is avoided as it has been reported to potentially exaggerate findings associated with laryngomalacia, reduce upper airway reflexes, and impair the arousal response resulting in increased sleep apnea severity.2,24 Also, decongestants are to be avoided to prevent altering the accuracy of the inferior turbinate evaluation.24

Beyond that, controversy remains as to which general anesthetic agent should be used. While nearly all anesthetics affect upper airway muscle tone to varying degrees, it is important to acknowledge that excessive sedation can produce an exaggeration of collapse and create false positives in the areas causing obstruction during sleep.22,23 This highlights the importance of being mindful and intentional about the anesthetic protocol used for DISE. Currently, multiple anesthetic protocols have been proposed (Table 1), but none have been universally accepted. The most common anesthetic agents used in pediatric DISE are propofol, midazolam, dexmedetomidine (DEX), ketamine, and inhalational agents (i.e. sevoflurane).23

Table 1.

Features of commonly used anesthetics for pediatric DISE.

Anesthetic agent Features
Propofol
  • Used for adult DISE

  • In pediatric DISE, criticized for its potential to cause excessive dose-dependent muscle relaxation and airway collapse

Midazolam
  • A commonly used benzodiazepine

  • Causes central apnea and peripheral muscle relaxation

DEX
  • It is a preferred medication for pediatric DISE due to its minimal effect on the airway

  • Studies have shown it to be less likely than propofol to cause upper airway obstruction

  • It replicates only non-REM sleep

  • It has been criticized for not providing adequate sedation as a single agent

Ketamine
  • It has minimal to no effect on airway patency and minimal effects on central respiratory drive

  • Causes hypersalivation, which can make DISE more difficult

Inhalational agents
  • Causes dose-dependent obstruction at various sites in the upper airway

DISE: drug-induced sleep endoscopy; DEX: dexmedetomidine; REM: rapid eye movement.

For adults, propofol is the anesthetic most frequently used for DISE and is titrated to a bispectral index between 50 and 75.9 For pediatric DISE, propofol has historically been criticized for its potential to cause excessive dose-dependent muscle relaxation and airway collapse; however, in 2020, Kirkham et al16 retrospectively compared DISE findings for children sedated with propofol versus DEX and did not find a significant difference in the degree of upper airway obstruction. Midazolam is a commonly used benzodiazepine for DISE but may cause both central apnea and peripheral muscle relaxation and obstruction.23 DEX is currently considered the preferred medication for pediatric DISE due to its minimal effect on the airway. Unfortunately, it replicates only non–rapid eye movement (REM) sleep and has been criticized for not providing adequate sedation as a single agent.25,26 Ketamine has minimal to no effect on the airway patency and minimal effects on central respiratory drive. However, ketamine does cause hypersalivation which can make DISE more difficult. Lastly, inhalational agents cause dose-dependent obstruction at various sites in the upper airway.22

Differences in anesthetic protocols make direct comparison of DISE results difficult. For example, a head-to-head comparison of propofol and DEX showed significant differences in upper airway scoring with DISE.27 A universally accepted anesthesia protocol is critically important but still not agreed upon as of the date of the publication of this manuscript.

Comparison of DISE to alternative diagnostic modalities

DISE has several advantages, including the ability to obtain a three-dimensional view of the airway and to concurrently offer surgical intervention in the same operative setting. Allowing for concurrent surgical intervention limits the need for multiple anesthetics and is more convenient for the families. One limitation of DISE is the ability to assess only one site of obstruction at a time.2 A second disadvantage is the scope's presence in the airway during the exam; some argue that the scope itself can stent open the airway during the exam, thereby changing the obstructive pattern.28 Despite these limitations, many providers and families feel the benefits outweigh these disadvantages and consider pairing the diagnostic DISE with a plan for therapeutic intervention in the same operative setting.2,13

In addition to DISE, several other modalities have been used to identify sites of obstruction for pediatric patients with OSA (Table 2). Cine magnetic resonance imaging (MR) is a procedure completed with the child sedated while spontaneously ventilated. The main advantage of cine MR is the ability to assess multiple levels of obstruction simultaneously; some feel this ability provides a better overall assessment of the airway.2 In contrast to DISE, MR allows visualization of the obstruction without instruments in the airway. Cine MR is also felt to be superior in its ability to assess for glossoptosis and to distinguish lingual tonsillar hypertrophy from base of tongue obstruction.29 The main disadvantages of cine MR are the expense of the study and the fact that surgical interventions would need to be completed in a separate setting.29 Interestingly, results for DISE and cine MR exams have not been found to specifically correlate; Clark et al in 2017 evaluated 15 children with OSA using DISE and cine MR and found discrepancies in the diagnostic results in 33% of the patients.30 Most of these diagnostic differences were attributed to the fact that the DISE exam found additional sites of obstruction that were not identified on MR.

Table 2.

Summary of advantages and disadvantages for imaging modalities assessing for sites of obstruction for patients with OSA.

Items Advantages Disadvantages
DISE Can perform surgical interventions at the same time, 3-D view Visualize one site at a time, scope stents the airway, difficult for OR planning
Cine MR Image multiple sites simultaneously, distinguish lingual tonsils from BOT Expensive, requires second anesthetic to perform surgical interventions
MLB Evaluate for SAL Low yield without specific comorbidities
CT 3D reconstructions, can do without sedation Radiation exposure
Cephalometrics Availability of plain film imaging Unknown sensitivity and specificity
Lateral neck films Availability of plain film imaging Patient is awake, sitting upright

OR: operating room; MR: magnetic resonance imaging; BOT: base of tongue; MLB: microlaryngoscopy/bronchoscopy; SAL: synchronous airway lesions; CT: computerized tomography.

Some providers perform tracheoscopy or microlaryngoscopy/bronchoscopy (MLB) at the same time as DISE to assess for synchronous airway lesions below the level of the glottis. A survey of pediatric otolaryngology providers in 2016 reported that 30% examine trachea/bronchi during DISE.13 Bliss et al31 found that only 5% of patients undergoing DISE had a synchronous airway lesion (SAL) identified with MLB and only a few of these required surgical correction. Their study concluded that in most cases concurrent MLB with DISE is unnecessary but may be considered when there is a history of intubation, prematurity, or other genetic, neurologic, or craniofacial comorbidities. Additionally, they highlight that the improved optics of the distal chip fiberoptic scopes used for DISE allow for easier visualization of the subglottis and may be able to identify patients who would benefit from further MLB evaluation.31

A study by Quinlan et al32 highlighted new computed tomography (CT) technology allowing for “dynamic 3-dimensional CT” imaging of the upper airway that does not require sedation. CT may be less favorable in pediatric patients, however, due to radiation exposure. Other reports have been published using cephalometrics and lateral neck films to identify sites of airway obstruction.33 Cephalometrics can use known measurements and ratios to determine areas of narrowing and possible obstruction. However, no known published studies identify the sensitivity and specificity of these calculated ratios.32 Lateral neck radiographs are widely available with relatively low cost, but the ability to identify obstruction may be limited by the 2-dimensional result, as well as the fact that the patient is sitting upright and is awake.

DISE scoring systems

An ideal scoring system would be standardized, validated, and universally accepted. A standardized scoring system would allow for objective outcome analysis after DISE between clinicians, institutions, and studies.2 Currently, there are several published scoring systems for DISE, but no consensus yet among providers.13 A review by Amos et al34 found that among 44 DISE studies, 21 different scoring systems were used. A study by Tejan et al35 used six different scoring systems on the same subset of surgically naïve pediatric patients undergoing DISE and concluded that all of the scoring systems lacked standardization of anatomic sites and rating scales. The six most common scoring systems used for pediatric DISE are summarized in Table 3. Each system is unique and varies by the anatomic sites, quantification, and characterization of airway obstruction. The VOTE system has been the most widely studied and is used in both adults and pediatric patients.36 This system is criticized for pediatric DISE due to its omission of the nasopharyngeal and supraglottic sites. The Chan scoring system, published in 2014,37 documents the percentage of obstruction at all sites other than lingual tonsils, which are described as present or absent. This system is similar to VOTE but includes the nasal, nasopharynx, and supraglottic sites. The Sleep Endoscopy Rating Scale (SERS) and the Bachar grading system evaluate similar sites but add an overall total score of upper airway obstruction.38,39 The Boudewyns scoring system uniquely characterizes the obstruction as fixed or dynamic and also allows for a generalized impression as to whether hypotonia is present or absent.40 The Fishman system evaluates the degree of obstruction at several sites but also factors in the quality of the exam, the confidence in the findings, and the severity of OSA, and asks the provider to determine the primary site of obstruction at the end of the exam.41 More recently, Williamson et al42 published another scoring system that evaluates obstruction at more sites than any of the six above systems: nasal airway, adenoid, palate, tonsils and lateral pharyngeal wall, tongue base, lingual tonsils, vallecula, epiglottis, aryepiglottic folds, and arytenoids. Currently, the use of multiple DISE scoring systems has created a lack of uniformity in how DISE is reported and studied. The need for a single universally agreed upon scoring system for DISE is imperative to move the field of pediatric sleep surgery forward.2

Table 3.

Commonly used scoring systems for pediatric drug-induced sleep endoscopy.

Scoring system Details
VOTE
  • Most studied

  • Used in children and adults

  • Concise and easy to use

  • Evaluates: velum, oropharynx, tongue base, epiglottis

  • Criticized in children because it omits the nasopharynx and supraglottis

Chan
  • Evaluates: nose, adenoid, velum, oropharynx/LPW, tongue base, lingual tonsils, epiglottis and supraglottis

  • Notes whether a jaw thrust or oral airway was required

SERS
  • Evaluates: nose, nasopharynx, velum, oropharynx/LPW, hypopharynx, larynx

  • Uses an overall score for upper airway obstruction

Bachar
  • Evaluates: nose, nasopharynx, palate and tonsils, tongue base, hypopharynx, and larynx

  • Uses an overall score for upper airway obstruction

Boudewyns
  • Evaluates: adenoids, tonsils, tongue base, palate, epiglottis, and supraglottis

  • Describes if obstruction is fixed or dynamic

  • Allows for generalized impression of hypotonia present or absent

Fishman
  • Evaluates: nose, nasopharynx, lateral walls, tongue base, supraglottis

  • Rates the degree of obstruction at several levels

  • Includes the quality of exam and the level of confidence in the findings

LPW: lateral pharyngeal wall.

DISE for surgically naïve patients

Traditionally, DISE has been used to assess the airway of children who had persistent OSA following AT. However, recent studies have shown utility in performing DISE on surgically naïve patients prior to AT. Gazzaz et al showed DISE affected decision-making in surgically naïve patients with snoring and SDB in up to 35% of children. Additionally, an alternate diagnosis or surgical target was identified by DISE in 54% of the patients.43 Chen et al7 reported DISE findings for patients with OSA and small tonsils and concluded that DISE was an effective way to determine the necessity of tonsillectomy. Miller et al reported that for surgically naïve patients with OSA and small non-obstructive tonsils, DISE was useful in identifying other sites of obstruction. The supraglottis was the most common site of obstruction found and supraglottoplasty was the most common procedure performed for this patient cohort.17 Kirkham et al reported 62 surgically naïve patients with OSA who were considered high risk for having persistence after traditional AT. These patients underwent DISE prior to any surgical intervention. Based on the DISE findings, 42% underwent AT, while 58% underwent treatment other than AT, including 18% who had multilevel surgery.16 This study demonstrates the ability of DISE to change the surgical management for pediatric patients with OSA who are surgically naïve. With this knowledge, the question then becomes whether DISE should be completed on all children prior to AT. Collu et al44 aimed to identify specific subgroups of patients for whom DISE should specifically be considered. They concluded that DISE is not as useful for “conventional” or classic cases. In this study, “conventional” patients were those with mild to moderate OSA and larger tonsils; DISE changed the plan in only 4.5% of the patients.

The ability of DISE to change management and DISE-directed surgical outcomes

Multiple studies have attested to the ability of DISE to change patient management, supporting it as a useful tool in the management of pediatric OSA. A prospective study by Hybaskova et al followed 51 pediatric patients with PSG-confirmed OSA. Based on history, physical exam, and PSG findings, a therapeutic plan was designed prior to DISE. Once DISE was performed, the surgical plan was changed in 60.8% of the patients based on the DISE findings.45 A recent systematic review of pediatric patients with OSA by Saniasiaya et al8 reported that DISE findings caused a change in the surgical plan for 30% of the patients. Similarly, Blanc et al46 reported 31 patients with OSA/hypopnea syndrome and found that DISE caused a change in surgical treatment of obstruction sites in 45% of the patients.

Using DISE to guide surgical decision making is described as DISE-directed surgery.47 Several investigators have examined DISE-directed surgical outcomes in children using standard objective criteria. Wootten et al assessed 26 patients retrospectively who had persistent OSA after AT. These patients underwent DISE with DISE-directed surgical interventions performed in the same setting. The study reported that 92% of patients experienced subjective improvement in symptoms as well as a decrease in mean obstructive apnea-hypopnea index (OAHI) from 7.0 ± 5.8 events per hour to 3.6 ± 1.8 events per hour. Only one patient had complete normalization of the OAHI, and the study failed to show a statistically significant difference in the pre- and post-operatively OAHI.47 A recent systematic review and meta-analysis by Socarras et al demonstrated that DISE-directed surgeries led to significant mean reductions in OAHI in children with persistent OSA following AT. However, the authors noted that complete resolution of the OSA is rarely observed even with DISE-directed surgery. The study highlights that factors such as medical co-morbidities and severe baseline OSA may contribute further to persistent disease.28 A study by He et al reported 56 pediatric patients with either persistent OSA following AT or infant OSA. These patients underwent DISE-directed surgery and had significant improvement in both OAHI and oxygen saturation nadir. The most commonly performed surgical procedures were adenoidectomy (48%), supraglottoplasty (38%), tonsillectomy (27%), lingual tonsillectomy (13%), nasal surgery (11%), pharyngoplasty (7%), and partial midline glossectomy (7%). The study found that DISE-directed surgery had better results for children with a lower AHI at baseline.48 Esteller et al49 showed that DISE-directed surgery led to significant improvement of OAHI in 20 otherwise healthy patients with prior AT. For surgically naïve patients, DISE-directed surgery has also been shown to decrease OAHI. Kirkham et al5 examined 62 surgically naïve children at high risk for persistent OSA and found significant reductions in OAHI and improvement in oxygen nadir following DISE directed intervention. As more DISE-directed data become available in the future, the specific role of DISE-directed surgery may become more apparent.

Future directions

In a recent publication by Bergeron et al,50 the authors described their institutional experience in performing DISE in the MR induction room compared to DISE completed in the traditional operating room. No major complications occurred, and total time of procedure was similar. There was a significant cost reduction when DISE was performed in the MR induction room. The downside remained that surgical interventions could not be incorporated in the MR setting.

Conclusion

DISE is helpful in its ability to guide the surgical management of pediatric patients with SDB and OSA. Its utility has been shown in managing patients with OSA who have already had AT as well as in certain surgically naïve patients. The field of pediatric sleep surgery ultimately needs a universally agreed upon anesthetic protocol and scoring system for DISE.

Declaration of competing interest

None.

Edited by Li-Shi Yang

Footnotes

Peer review under responsibility of Chinese Medical Association.

References

  • 1.Lumeng J.C., Chervin R.D. Epidemiology of pediatric obstructive sleep apnea. Proc Am Thorac Soc. 2008;5:242–252. doi: 10.1513/pats.200708-135MG. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Wilcox L.J., Bergeron M., Reghunathan S., Ishman S.L. An updated review of pediatric drug-induced sleep endoscopy. Laryngoscope Invest Otolaryngol. 2017;2:423–431. doi: 10.1002/lio2.118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Dutt N., Janmeja A.K., Mohapatra P.R., Singh A.K. Quality of life impairment in patients of obstructive sleep apnea and its relation with the severity of disease. Lung India. 2013;30:289–294. doi: 10.4103/0970-2113.120603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Marcus C.L., Brooks L.J., Draper K.A. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2012;130:e714–e755. doi: 10.1542/peds.2012-1672. [DOI] [PubMed] [Google Scholar]
  • 5.Friedman M., Wilson M., Lin H.C., Chang H.W. Updated systematic review of tonsillectomy and adenoidectomy for treatment of pediatric obstructive sleep apnea/hypopnea syndrome. Otolaryngol Head Neck Surg. 2009;140:800–808. doi: 10.1016/j.otohns.2009.01.043. http://www.ncbi.nlm.nih.gov/pubmed/19467393 [DOI] [PubMed] [Google Scholar]
  • 6.Lee J.J., Ford M.D., Tobey A.B., Jabbour N. Diagnosing tongue base obstruction in pierre robin sequence infants: sleep vs awake endoscopy. Cleft Palate Craniofac J. 2018;55:692–696. doi: 10.1177/1055665618756706. [DOI] [PubMed] [Google Scholar]
  • 7.Chen J., He S. Drug-induced sleep endoscopy-directed adenotonsillectomy in pediatric obstructive sleep apnea with small tonsils. PLoS One. 2019;14 doi: 10.1371/journal.pone.0212317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Saniasiaya J., Kulasegarah J. Outcome of drug induced sleep endoscopy directed surgery in paediatrics obstructive sleep apnoea: a systematic review. Int J Pediatr Otorhinolaryngol. 2020;139:110482. doi: 10.1016/j.ijporl.2020.110482. [DOI] [PubMed] [Google Scholar]
  • 9.Charakorn N., Kezirian E.J. Drug-induced sleep endoscopy. Otolaryngol Clin North Am. 2016;49(6):1359–1372. doi: 10.1016/j.otc.2016.06.002. [DOI] [PubMed] [Google Scholar]
  • 10.Rodriguez-Bruno K., Goldberg A.N., McCulloch C.E., Kezirian E.J. Test-retest reliability of drug-induced sleep endoscopy. Otolaryngol Head Neck Surg. 2009;140:646–651. doi: 10.1016/j.otohns.2009.01.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Akkina S.R., Ma C.C., Kirkham E.M., Horn D.L., Chen M.L., Parikh S.R. Does drug induced sleep endoscopy-directed surgery improve polysomnography measures in children with Down Syndrome and obstructive sleep apnea. Acta Otolaryngol. 2018;138:1009–1013. doi: 10.1080/00016489.2018.1504169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Manickam P.V., Shott S.R., Boss E.F. Systematic review of site of obstruction identification and non-CPAP treatment options for children with persistent pediatric obstructive sleep apnea. Laryngoscope. 2016;126:491–500. doi: 10.1002/lary.25459. [DOI] [PubMed] [Google Scholar]
  • 13.Friedman N.R., Parikh S.R., Ishman S.L. The current state of pediatric drug-induced sleep endoscopy. Laryngoscope. 2017;127:266–272. doi: 10.1002/lary.26091. http://www.ncbi.nlm.nih.gov/pubmed/27311407 [DOI] [PubMed] [Google Scholar]
  • 14.Park J.S., Chan D.K., Parikh S.R., Meyer A.K., Rosbe K.W. Surgical outcomes and sleep endoscopy for children with sleep-disordered breathing and hypotonia. Int J Pediatr Otorhinolaryngol. 2016;90:99–106. doi: 10.1016/j.ijporl.2016.09.004. [DOI] [PubMed] [Google Scholar]
  • 15.Costa D.J., Mitchell R. Adenotonsillectomy for obstructive sleep apnea in obese children: a meta-analysis. Otolaryngol Head Neck Surg. 2009;140:455–460. doi: 10.1016/j.otohns.2008.12.038. [DOI] [PubMed] [Google Scholar]
  • 16.Kirkham E., Ma C.C., Filipek N. Polysomnography outcomes of sleep endoscopy-directed intervention in surgically naïve children at risk for persistent obstructive sleep apnea. Sleep Breath. 2020;24:1143–1150. doi: 10.1007/s11325-019-02006-y. [DOI] [PubMed] [Google Scholar]
  • 17.Miller C., Purcell P.L., Dahl J.P. Clinically small tonsils are typically not obstructive in children during drug-induced sleep endoscopy. Laryngoscope. 2017;127:1943–1949. doi: 10.1002/lary.26447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Richter G.T., Rutter M.J., deAlarcon A., Orvidas L.J., Thompson D.M. Late-onset laryngomalacia: a variant of disease. Arch Otolaryngol Head Neck Surg. 2008;134:75–80. doi: 10.1001/archoto.2007.17. [DOI] [PubMed] [Google Scholar]
  • 19.Love H., Slaven J.E., Mitchell R.M., Bandyopadhyay A. Outcomes of OSA in surgically naïve young children with and without DISE identified laryngomalacia. Int J Pediatr Otorhinolaryngol. 2020;138:110351. doi: 10.1016/j.ijporl.2020.110351. [DOI] [PubMed] [Google Scholar]
  • 20.Camacho M., Dunn B., Torre C. Supraglottoplasty for laryngomalacia with obstructive sleep apnea: a systematic review and meta-analysis. Laryngoscope. 2016;126:1246–1255. doi: 10.1002/lary.25827. [DOI] [PubMed] [Google Scholar]
  • 21.Caloway C.L., Diercks G.R., Keamy D. Update on hypoglossal nerve stimulation in children with down syndrome and obstructive sleep apnea. Laryngoscope. 2020;130:E263–E267. doi: 10.1002/lary.28138. [DOI] [PubMed] [Google Scholar]
  • 22.Adler A.C., Musso M.F., Mehta D.K., Chandrakantan A. Pediatric drug induced sleep endoscopy: a simple sedation recipe. Ann Otol Rhinol Laryngol. 2020;129:428–433. doi: 10.1177/0003489419892292. [DOI] [PubMed] [Google Scholar]
  • 23.Liu K.A., Liu C.C., Alex G., Szmuk P., Mitchell R.B. Anesthetic management of children undergoing drug-induced sleep endoscopy: a retrospective review. Int J Pediatr Otorhinolaryngol. 2020;139:110440. doi: 10.1016/j.ijporl.2020.110440. [DOI] [PubMed] [Google Scholar]
  • 24.Ehsan Z., Mahmoud M., Shott S.R., Amin R.S., Ishman S.L. The effects of anesthesia and opioids on the upper airway: a systematic review. Laryngoscope. 2016;126:270–284. doi: 10.1002/lary.25399. [DOI] [PubMed] [Google Scholar]
  • 25.Shteamer J.W., Dedhia R.C. Sedative choice in drug-induced sleep endoscopy: a neuropharmacology-based review. Laryngoscope. 2017;127:273–279. doi: 10.1002/lary.26132. [DOI] [PubMed] [Google Scholar]
  • 26.Nelson L.E., Lu J., Guo T., Saper C.B., Franks N.P., Maze M. The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology. 2003;98:428–436. doi: 10.1097/00000542-200302000-00024. [DOI] [PubMed] [Google Scholar]
  • 27.Cho J.S., Soh S., Kim E.J. Comparison of three sedation regimens for drug-induced sleep endoscopy. Sleep Breath. 2015;19:711–717. doi: 10.1007/s11325-015-1127-9. [DOI] [PubMed] [Google Scholar]
  • 28.Socarras M.A., Landau B.P., Durr M.L. Diagnostic techniques and surgical outcomes for persistent pediatric obstructive sleep apnea after adenotonsillectomy: a systematic review and meta-analysis. Int J Pediatr Otorhinolaryngol. 2019;121:179–187. doi: 10.1016/j.ijporl.2019.02.030. [DOI] [PubMed] [Google Scholar]
  • 29.Shott S.R., Donnelly L.F. Cine magnetic resonance imaging: evaluation of persistent airway obstruction after tonsil and adenoidectomy in children with Down syndrome. Laryngoscope. 2004;114:1724–1729. doi: 10.1097/00005537-200410000-00009. [DOI] [PubMed] [Google Scholar]
  • 30.Clark C., Ulualp S.O. Multimodality assessment of upper airway obstruction in children with persistent obstructive sleep apnea after adenotonsillectomy. Laryngoscope. 2017;127:1224–1230. doi: 10.1002/lary.26174. [DOI] [PubMed] [Google Scholar]
  • 31.Bliss M., Yanamadala S., Koltai P. Utility of concurrent direct laryngoscopy and bronchoscopy with drug induced sleep endoscopy in pediatric patients with obstructive sleep apnea. Int J Pediatr Otorhinolaryngol. 2018;110:34–36. doi: 10.1016/j.ijporl.2018.04.009. [DOI] [PubMed] [Google Scholar]
  • 32.Quinlan C.M., Otero H., Tapia I.E. Upper airway visualization in pediatric obstructive sleep apnea. Paediatr Respir Rev. 2019;32:48–54. doi: 10.1016/j.prrv.2019.03.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Major M.P., Flores-Mir C., Major P.W. Assessment of lateral cephalometric diagnosis of adenoid hypertrophy and posterior upper airway obstruction: a systematic review. Am J Orthod Dentofacial Orthop. 2006;130:700–708. doi: 10.1016/j.ajodo.2005.05.050. [DOI] [PubMed] [Google Scholar]
  • 34.Amos J.M., Durr M.L., Nardone H.C., Baldassari C.M., Duggins A., Ishman S.L. Systematic review of drug-induced sleep endoscopy scoring systems. Otolaryngol Head Neck Surg. 2018;158:240–248. doi: 10.1177/0194599817737966. [DOI] [PubMed] [Google Scholar]
  • 35.Tejan J., Medina M., Ulualp S.O. Comparative assessment of drug-induced sleep endoscopy scoring systems in pediatric sleep apnea. Laryngoscope. 2019;129:2195–2198. doi: 10.1002/lary.27829. [DOI] [PubMed] [Google Scholar]
  • 36.Kezirian E.J., Hohenhorst W., de Vries N. Drug-induced sleep endoscopy: the VOTE classification. Eur Arch Otorhinolaryngol. 2011;268:1233–1236. doi: 10.1007/s00405-011-1633-8. [DOI] [PubMed] [Google Scholar]
  • 37.Chan D.K., Liming B.J., Horn D.L., Parikh S.R. A new scoring system for upper airway pediatric sleep endoscopy. JAMA Otolaryngol Head Neck Surg. 2014;140:595–602. doi: 10.1001/jamaoto.2014.612. [DOI] [PubMed] [Google Scholar]
  • 38.Lam D.J., Weaver E.M., Macarthur C.J. Assessment of pediatric obstructive sleep apnea using a drug-induced sleep endoscopy rating scale. Laryngoscope. 2016;126:1492–1498. doi: 10.1002/lary.25842. [DOI] [PubMed] [Google Scholar]
  • 39.Bachar G., Nageris B., Feinmesser R. Novel grading system for quantifying upper-airway obstruction on sleep endoscopy. Lung. 2012;190:313–318. doi: 10.1007/s00408-011-9367-3. [DOI] [PubMed] [Google Scholar]
  • 40.Boudewyns A., Verhulst S., Maris M., Saldien V., Van de Heyning P. Drug-induced sedation endoscopy in pediatric obstructive sleep apnea syndrome. Sleep Med. 2014;15:1526–1531. doi: 10.1016/j.sleep.2014.06.016. [DOI] [PubMed] [Google Scholar]
  • 41.Fishman G., Zemel M., DeRowe A., Sadot E., Sivan Y., Koltai P.J. Fiber-optic sleep endoscopy in children with persistent obstructive sleep apnea: inter-observer correlation and comparison with awake endoscopy. Int J Pediatr Otorhinolaryngol. 2013;77:752–755. doi: 10.1016/j.ijporl.2013.02.002. [DOI] [PubMed] [Google Scholar]
  • 42.Williamson A., 4th, Ibrahim S.R., Coutras S.W., Carr M.M. Pediatric drug-induced sleep endoscopy: technique and scoring system. Cureus. 2020;12 doi: 10.7759/cureus.10765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Gazzaz M.J., Isaac A., Anderson S., Alsufyani N., Alrajhi Y., El-Hakim H. Does drug-induced sleep endoscopy change the surgical decision in surgically naïve non-syndromic children with snoring/sleep disordered breathing from the standard adenotonsillectomy? A retrospective cohort study. J Otolaryngol Head Neck Surg. 2017;46:12. doi: 10.1186/s40463-017-0190-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Collu M.A., Esteller E., Lipari F. A case-control study of Drug-Induced Sleep Endoscopy (DISE) in pediatric population: a proposal for indications. Int J Pediatr Otorhinolaryngol. 2018;108:113–119. doi: 10.1016/j.ijporl.2018.02.038. [DOI] [PubMed] [Google Scholar]
  • 45.Hybášková J., Jor O., Novák V., Zeleník K., Matoušek P., Komínek P. Drug-induced sleep endoscopy changes the treatment concept in patients with obstructive sleep apnoea. Biomed Res Int. 2016;2016:6583216. doi: 10.1155/2016/6583216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Blanc F., Kennel T., Merklen F., Blanchet C., Mondain M., Akkari M. Contribution of drug-induced sleep endoscopy to the management of pediatric obstructive sleep apnea/hypopnea syndrome. Eur Ann Otorhinolaryngol Head Neck Dis. 2019;136:447–454. doi: 10.1016/j.anorl.2019.09.001. [DOI] [PubMed] [Google Scholar]
  • 47.Wootten C.T., Chinnadurai S., Goudy S.L. Beyond adenotonsillectomy: outcomes of sleep endoscopy-directed treatments in pediatric obstructive sleep apnea. Int J Pediatr Otorhinolaryngol. 2014;78:1158–1162. doi: 10.1016/j.ijporl.2014.04.041. [DOI] [PubMed] [Google Scholar]
  • 48.He S., Peddireddy N.S., Smith D.F. Outcomes of drug-induced sleep endoscopy-directed surgery for pediatric obstructive sleep apnea. Otolaryngol Head Neck Surg. 2018;158:559–565. doi: 10.1177/0194599817740332. [DOI] [PubMed] [Google Scholar]
  • 49.Esteller E., Villatoro J.C., Agüero A. Outcome of drug-induced sleep endoscopy-directed surgery for persistent obstructive sleep apnea after adenotonsillar surgery. Int J Pediatr Otorhinolaryngol. 2019;120:118–122. doi: 10.1016/j.ijporl.2019.02.004. [DOI] [PubMed] [Google Scholar]
  • 50.Bergeron M., Lee D.R., DeMarcantonio M.A. Safety and cost of drug-induced sleep endoscopy outside the operating room. Laryngoscope. 2020;130:2076–2080. doi: 10.1002/lary.28397. [DOI] [PubMed] [Google Scholar]

Articles from World Journal of Otorhinolaryngology - Head and Neck Surgery are provided here courtesy of Chinese Medical Association

RESOURCES